The Solution Structure of FUS Bound to RNA Reveals a Bipartite Mode of RNA Recognition with Both Sequence and Shape Specificity.
Arg-Gly-Gly
RNA recognition motif
alternative-splicing
amyotrophic lateral sclerosis
frontotemporal lobar degeneration
fused in sarcoma
nuclear magnetic resonance spectroscopy
protein-RNA complex
ribonucleoprotein
zinc finger
Journal
Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571
Informations de publication
Date de publication:
07 02 2019
07 02 2019
Historique:
received:
07
05
2018
revised:
21
09
2018
accepted:
13
11
2018
pubmed:
26
12
2018
medline:
31
5
2019
entrez:
25
12
2018
Statut:
ppublish
Résumé
Fused in sarcoma (FUS) is an RNA binding protein involved in regulating many aspects of RNA processing and linked to several neurodegenerative diseases. Transcriptomics studies indicate that FUS binds a large variety of RNA motifs, suggesting that FUS RNA binding might be quite complex. Here, we present solution structures of FUS zinc finger (ZnF) and RNA recognition motif (RRM) domains bound to RNA. These structures show a bipartite binding mode of FUS comprising of sequence-specific recognition of a NGGU motif via the ZnF and an unusual shape recognition of a stem-loop RNA via the RRM. In addition, sequence-independent interactions via the RGG repeats significantly increase binding affinity and promote destabilization of structured RNA conformation, enabling additional binding. We further show that disruption of the RRM and ZnF domains abolishes FUS function in splicing. Altogether, our results rationalize why deciphering the RNA binding mode of FUS has been so challenging.
Identifiants
pubmed: 30581145
pii: S1097-2765(18)30982-1
doi: 10.1016/j.molcel.2018.11.012
pii:
doi:
Substances chimiques
FUS protein, human
0
RNA-Binding Protein FUS
0
RNA
63231-63-0
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
490-504.e6Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.